Eieling Technology Limited, a startup born out of The Hong Kong Polytechnic University's support, has taken the lead in launching the "LiverCare – Hong Kong 10 Million Liver Scans Program." This initiative aims to enhance public understanding of liver disease prevention, advocating for early detection and treatment to mitigate its impact.
At the Program's inauguration, key figures such as Prof. Christopher CHAO and Prof. ZHENG Yongping from PolyU, alongside representatives from various institutions like the Hong Kong Trade Development Council and the University of Hong Kong, gathered to mark the occasion. Mr. Xiaojia JIA, CEO of Eieling Technology Limited, and Ms. Mildred LAW from the Hong Kong Liver Foundation also graced the event.
PolyU, known for its commitment to practical applications of its research, will spearhead the Program. Beginning in July, the university will commence liver fibrosis and fatty liver screenings for its staff using an innovative device called Liverscan—a compact, wireless ultrasound imaging tool. Staff members are encouraged to participate in a two-year follow-up study, allowing researchers to analyze data collected during this period. Through this, the research team intends to investigate the significance of maintaining a balanced diet, engaging in regular exercise, and undergoing routine liver screenings to monitor disease progression.
PolyU envisions that this Program will not only raise awareness about liver disease prevention but also facilitate early intervention, ultimately diminishing the health risks posed by liver ailments to the population.
In essence, Eieling Technology Limited, supported by PolyU, launched the "LiverCare – Hong Kong 10 Million Liver Scans Program" to educate the public on liver disease prevention and promote timely intervention. PolyU's proactive involvement, exemplifying its commitment to practical research applications, includes conducting screenings using the Liverscan device and conducting a two-year follow-up study.
